↓ Skip to main content

Using health markets to improve access to medicines: three case studies

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, May 2016
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)

Mentioned by

twitter
3 tweeters

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
14 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Using health markets to improve access to medicines: three case studies
Published in
Journal of Pharmaceutical Policy and Practice, May 2016
DOI 10.1186/s40545-016-0067-5
Pubmed ID
Authors

Zubin Shroff, Maryam Bigdeli, Zaheer-Ud-Din Babar, Anita Wagner, Abdul Ghaffar, David H Peters

Abstract

This editorial introduces a series of case studies that together highlight the use of health market interventions to improve access to medicines in low-and-middle income countries (LMICs). It underscores the added value of using a systems approach for a holistic understanding of how these interventions interact with the rest of the health system and the intended and unintended consequences that result. It goes on to summarize key findings from each of the studies and concludes with lessons for decision-makers on the design and implementation of market based interventions in LMIC health systems.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 7%
Unknown 13 93%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 29%
Other 2 14%
Researcher 2 14%
Student > Doctoral Student 1 7%
Student > Ph. D. Student 1 7%
Other 0 0%
Unknown 4 29%
Readers by discipline Count As %
Medicine and Dentistry 4 29%
Pharmacology, Toxicology and Pharmaceutical Science 3 21%
Nursing and Health Professions 2 14%
Decision Sciences 1 7%
Unknown 4 29%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 May 2016.
All research outputs
#3,286,818
of 7,820,779 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#63
of 109 outputs
Outputs of similar age
#105,589
of 268,331 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#5
of 7 outputs
Altmetric has tracked 7,820,779 research outputs across all sources so far. This one has received more attention than most of these and is in the 57th percentile.
So far Altmetric has tracked 109 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.9. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 268,331 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.